颈动脉血运重建经颈动脉途径与颈动脉内膜切除术三年生存的倾向性评分匹配分析:基于血管质量倡议医保链接数据库
基于VQI-Medicare链接数据库,比较经颈动脉血运重建(TCAR)与颈动脉内膜切除术(CEA)的1年和3年生存。43,714例CEA与8,089例TCAR经1:1倾向性评分匹配为7,351对。匹配队列中1年死亡无差异(HR=1.13;95%CI 0.99-1.30;P=0.065),3年TCAR死亡风险轻度增加(HR=1.16;95%CI 1.04-1.30;P=0.008),仅症状性患者中持续存在(HR=1.33;95%CI 1.08-1.63;P=0.008)。
要点
- 匹配队列1年死亡TCAR与CEA无显著差异(HR=1.13;95%CI 0.99-1.30;P=0.065)。
- 3年死亡TCAR轻度增加(HR=1.16;95%CI 1.04-1.30;P=0.008),仅症状性患者中持续(HR=1.33;95%CI 1.08-1.63;P=0.008)。
- 作者认为症状性患者3年死亡轻度增加可能受更严重合并症混杂,需随机对照试验进一步确定TCAR作用。
核心结论
- 1年死亡率TCAR与CEA相似,与症状状态无关。
- 症状性患者TCAR的3年死亡风险轻度增加,作者认为可能受更严重合并症混杂。
- 作者认为需随机对照试验进一步确定TCAR在需颈动脉血运重建的标准风险患者中的作用。
研究设计与样本
- 查询VISION数据库2016年9月至2019年12月所有接受CEA和TCAR的患者。
- 采用不放回1:1倾向性评分匹配产生两个匹配良好的队列。
- 使用Kaplan-Meier估计和Cox回归分析,探索性分析使用基于索赔的算法比较卒中率。
主要发现
- 研究期间43,714例接受CEA,8,089例接受TCAR。
- TCAR队列患者更老且更可能有严重合并症。
- 匹配产生7,351对TCAR和CEA。
- 匹配队列1年死亡无差异(HR=1.13;95%CI 0.99-1.30;P=0.065)。
- 3年TCAR死亡风险轻度增加(HR=1.16;95%CI 1.04-1.30;P=0.008),仅症状性患者中持续(HR=1.33;95%CI 1.08-1.63;P=0.008)。
关键数值与推荐
- 匹配队列1年死亡HR=1.13;95%CI 0.99-1.30;P=0.065。
- 3年死亡HR=1.16;95%CI 1.04-1.30;P=0.008。
- 症状性患者3年死亡HR=1.33;95%CI 1.08-1.63;P=0.008。
临床怎么用
- 作者认为需随机对照试验进一步确定TCAR在需颈动脉血运重建的标准风险患者中的作用。
局限性
- 作者认为症状性患者TCAR的3年死亡轻度增加可能受更严重合并症混杂。
- 探索性分析提示需验证基于索赔的卒中判定措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Carotid endarterectomy (CEA) remains the gold standard procedure for carotid revascularization. Transfemoral carotid artery stenting (TFCAS) was introduced as a minimally invasive alternative procedure in patients who are at high risk for surgery. However, TFCAS was associated with an increased risk of stroke and death compared to CEA. BACKGROUND: Transcarotid artery revascularization (TCAR) has outperformed TFCAS in several prior studies and has shown similar perioperative and 1-year outcomes compared with CEA. We aimed to compare the 1-year and 3-year outcomes of TCAR versus CEA in the Vascular Quality Initiative (VQI)-Medicare-Linked [Vascular Implant Surveillance and Interventional Outcomes Network (VISION)] database. METHODS: The VISION database was queried for all patients undergoing CEA and TCAR between September 2016 to December 2019. The primary outcome was 1-year and 3-year survival. One-to-one propensity-score matching (PSM) without replacement was used to produce 2 well-matched cohorts. Kaplan-Meier estimates, and Cox regression was used for analyses. Exploratory analyses compared stroke rates using claims-based algorithms for comparison. RESULTS: A total of 43,714 patients underwent CEA and 8089 patients underwent TCAR during the study period. Patients in the TCAR cohort were older and were more likely to have severe comorbidities. PSM produced two well-matched cohorts of 7351 pairs of TCAR and CEA. In the matched cohorts, there were no differences in 1-year death [hazard ratio (HR)=1.13; 95% CI, 0.99-1.30; P =0.065]. At 3-years, TCAR was associated with slight increased risk of death (HR=1.16; 95% CI, 1.04-1.30; P =0.008). When stratifying by initial symptomatic presentation, the increased 3-year death associated with TCAR persisted only in symptomatic patients (HR=1.33; 95% CI, 1.08-1.63; P =0.008). Exploratory analyses of postoperative stroke rates using administrative sources suggested that validated measures of claims-based stroke ascertainment are necessary. CONCLUSIONS: In this large multi-institutional PSM analysis with robust Medicare-linked follow-up for survival analysis, the rate of death at 1 year was similar in TCAR and CEA regardless of symptomatic status. The slight increase in the risk of 3-year death in symptomatic patients undergoing TCAR is likely confounded by more severe comorbidities despite matching. A randomized controlled trial comparing TCAR to CEA is necessary to further determine the role of TCAR in standard-risk patients requiring carotid revascularization.
引用
- Zarrintan S, Elsayed N, Patel RJ, et al. Propensity-Score Matched Analysis of Three Years Survival of Trans Carotid Artery Revascularization Versus Carotid Endarterectomy in the Vascular Quality Initiative Medicare-Linked Database. Ann Surg. 2023. PMID: 37436847. doi:10.1097/SLA.0000000000006009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。